A phase II trial with RFS2000 (rubitecan) in patients with advanced non-small cell lung cancer

S. Baka, M. Ranson, P. Lorigan, S. Danson, K. Linton, I. Hoogendam, K. Mettinger, N. Thatcher

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'A phase II trial with RFS2000 (rubitecan) in patients with advanced non-small cell lung cancer'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science

    Medicine and Dentistry